Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.

Parrella A, Gold M, Braunack-Mayer A, Baghurst P, Marshall H.

Hum Vaccin Immunother. 2014;10(3):747-54.

2.

Parental perspectives of vaccine safety and experience of adverse events following immunisation.

Parrella A, Gold M, Marshall H, Braunack-Mayer A, Baghurst P.

Vaccine. 2013 Apr 12;31(16):2067-74. doi: 10.1016/j.vaccine.2013.02.011.

PMID:
23422146
3.

Annual report: surveillance of adverse events following immunisation in Australia, 2008.

Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G.

Commun Dis Intell Q Rep. 2009 Dec;33(4):365-81.

4.

Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.

Guo B, Page A, Wang H, Taylor R, McIntyre P.

Vaccine. 2013 Jan 11;31(4):603-17. doi: 10.1016/j.vaccine.2012.11.051. Review.

PMID:
23200940
5.

Consumer reporting of adverse events following immunization.

Clothier HJ, Selvaraj G, Easton ML, Lewis G, Crawford NW, Buttery JP.

Hum Vaccin Immunother. 2014;10(12):3726-30. doi: 10.4161/hv.34369. Erratum in: Hum Vaccin Immunother. 2015;11(5):1294.

6.

Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.

Parrella A, Gold M, Marshall H, Braunack-Mayer A, Watson M, Baghurst P.

Hum Vaccin Immunother. 2012 May;8(5):662-7. doi: 10.4161/hv.19478.

PMID:
22634441
7.

Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany.

Muehlhans S, von Kleist M, Gretchukha T, Terhardt M, Fegeler U, Maurer W, Namazova-Baranova L, Gaedicke G, Baranov A, Rath B.

Paediatr Drugs. 2014 Aug;16(4):321-30. doi: 10.1007/s40272-014-0075-3.

PMID:
24849291
8.

Surveillance of adverse events following immunisation: Australia, 2000-2002.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, Purcell P, Isaacs D.

Commun Dis Intell Q Rep. 2003;27(3):307-23.

9.

Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.

Clothier HJ, Hosking L, Crawford NW, Russell M, Easton ML, Quinn JA, Buttery JP.

Drug Saf. 2015 Jan;38(1):79-86. doi: 10.1007/s40264-014-0248-6.

PMID:
25475539
10.

Healthcare providers' knowledge, experience and challenges of reporting adverse events following immunisation: a qualitative study.

Parrella A, Braunack-Mayer A, Gold M, Marshall H, Baghurst P.

BMC Health Serv Res. 2013 Aug 15;13:313. doi: 10.1186/1472-6963-13-313.

11.

Reporting of adverse events following immunization in Australia.

Isaacs D, Lawrence G, Boyd I, Ronaldson K, McEwen J.

J Paediatr Child Health. 2005 Apr;41(4):163-6. Review.

PMID:
15813867
12.

Annual report: surveillance of adverse events following immunisation in Australia, 2007.

Lawrence G, Gold MS, Hill R, Deeks S, Glasswell A, McIntyre PB.

Commun Dis Intell Q Rep. 2008 Dec;32(4):371-87.

13.

Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.

Schumacher Z, Bourquin C, Heininger U.

Vaccine. 2010 May 28;28(24):4059-64. doi: 10.1016/j.vaccine.2010.04.002.

PMID:
20406662
14.

Annual report: Surveillance of adverse events following immunisation in Australia, 2005.

Lawrence G, Boyd I, McIntyre P, Isaacs D.

Commun Dis Intell Q Rep. 2006;30(3):319-33.

15.

Safety monitoring of a new pentavalent vaccine in the expanded programme on immunisation in Ghana.

Dodoo AN, Renner L, van Grootheest AC, Labadie J, Antwi-Agyei KO, Hayibor S, Addison J, Pappoe V, Appiah-Danquah A.

Drug Saf. 2007;30(4):347-56.

PMID:
17408311
16.

A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.

De Alwis KN, Abeysinghe MR, Wickramesinghe AR, Wijesinghe PR.

Vaccine. 2014 Feb 12;32(8):924-30. doi: 10.1016/j.vaccine.2013.12.047.

PMID:
24406391
17.

Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.

Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW.

Vaccine. 2015 Mar 24;33(13):1602-7. doi: 10.1016/j.vaccine.2015.02.008.

PMID:
25698493
18.

Surveillance of adverse events following immunisation: Australia 2002 to 2003.

Lawrence G, Boyd I, McIntyre P, Isaacs D.

Commun Dis Intell Q Rep. 2004;28(3):324-38.

19.

Active surveillance for adverse events following immunization.

Crawford NW, Clothier H, Hodgson K, Selvaraj G, Easton ML, Buttery JP.

Expert Rev Vaccines. 2014 Feb;13(2):265-76. doi: 10.1586/14760584.2014.866895. Review.

PMID:
24350637
20.

Annual report: surveillance of adverse events following immunisation in Australia, 2009.

Mahajan D, Roomiani I, Gold MS, Lawrence GL, McIntyre PB, Menzies RI.

Commun Dis Intell Q Rep. 2010 Sep;34(3):259-76.

Supplemental Content

Support Center